July 26th 2024
Using NHANES data, researchers calculated AGILE 3 + and AGILE 4 scores to determine the prevalence of advanced fibrosis and cirrhosis in patients with MASLD in the US.
Alcohol Use Disorder Diagnosis, Treatment Associated with Decreased Risk of Mortality
October 23rd 2023Presented at ACG 2023, findings from a retrospective cohort analysis revealed patients with ALD diagnosed with and prescribed at least 1 medication for alcohol use disorder had a decreased risk of mortality.
The Rise of Obesity in the US: Recognizing Gastrointestinal and Hepatic Comorbidities
October 6th 2023Obesity rates in the US have skyrocketed, and so has the prevalence of several comorbid gastrointestinal and hepatic diseases - not all patients know their risks or have the financial means to take preventative measures.
Study Highlights Efficacy of ALT/HDL-C Ratio as Biomarker for NAFLD
September 22nd 2023Investigators suggested an ALT/HDL-C ratio of 15.97 as a screening threshold for identifying NAFLD, noting its increased effectiveness compared to ALT, HDL-C, the aspartate aminotransferase to HDL-C ratio, and the gamma-glutamyl transferase to HDL-C ratio.